Trial Interactive Client Spotlight
TransPerfect assisted Karyopharm Therapeutics in expediting the FDA drug approval process for myeloma patients. Karyopharm approached TransPerfect with two challenges: preparing their trial master file (TMF) for inspections and translating over 60,000 words of critical documentation for an NDA submission within a weekend. Utilizing their Trial Interactive technology, TMF services, and translation expertise, TransPerfect enabled Karyopharm to meet the FDA's deadlines and successfully submit their drug application. As a result, Karyopharm's first product, XPOVIO, received FDA approval.